The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
Ribonucleases are a superfamily of RNA-cleaving enzymes that can be cytotoxic since the cleavage of RNA makes its information indecipherable. Ranpirnase is a novel ribonuclease which preferentially degrades tRNA, thus leading to an inhibition of protein synthesis and, ultimately, to cytostasis and c...
Main Authors: | Luciano Mutti, Giovanni Gaudino |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-12-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://oncologyreviews.org/index.php/or/article/view/110 |
Similar Items
-
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011-12-01) -
Ribonucleases with Antiproliferative Properties: Molecular Biological and Biochemical Characteristics
by: VS Pokrovskii, et al.
Published: (2016-04-01) -
Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro
by: Todd G. Smith, et al.
Published: (2020-02-01) -
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
by: Camillo Porta, et al.
Published: (2008-08-01) -
The purification and properties of ribonucleases
by: Roy, Kenneth Leo Joseph
Published: (2011)